Praxis Precision Medicines

About:

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Website: https://praxismedicines.com/

Twitter/X: PraxisMedicine

Top Investors: Cormorant Asset Management, Point72 Ventures, Vida Ventures, Novo Holdings, Surveyor Capital

Description:

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain.